Stephanie M. Perkins, MD - Washington ...

Dr. Stephanie Perkins, M.D.

Claim this profile

Washington University School of Medicine

Studies Brain Tumor
Studies Cerebral Gliomas
9 reported clinical trials
13 drugs studied

Affiliated Hospitals

Image of trial facility.
Washington University School Of Medicine
Image of trial facility.
Washington University

Clinical Trials Stephanie Perkins, M.D. is currently running

Image of trial facility.

Cognitive Testing + Brain Imaging

for Childhood Brain Cancer

The investigators will focus on three cohorts of brain tumor patients aged, 4-18 years, to answer two critical questions: 1) Can the investigators acquire high quality data relevant to cognitive function during the peri-diagnostic period and, 2) can the investigators develop predictive models for cognitive outcomes using serial examination of functional imaging and cognitive function. Any patient with a newly diagnosed brain tumor aged 4-18 will be eligible for enrollment in cohort 1. Only patients with previously diagnosed tumors of the posterior fossa will be eligible for cohort 2. For cohort 3, eligible patients will include patients with a clinical diagnosis of posterior fossa syndrome with physical impairments that prohibit completion of the NIH Toolbox Cognitive Battery. The investigators have decided to expand the eligible tumor types to better capture the most significant deficit variability that can be caused by tumors outside the posterior fossa. Thus, this focus will provide a platform to analyze the impact that different tumor types and different standard treatments have on cognitive dysfunction. The rationale for inclusion of subjects on cohort 3 is that posterior fossa syndrome is one of the most cognitively devastating diagnoses following a posterior fossa surgery. The causes of posterior fossa syndrome and unknown and there are currently no interventions to improve symptoms. RsfcMRI would offer a novel and non-invasive assessment of posterior fossa syndrome patients by assessing connectivity within and outside of the cerebellum. Expanding the tumor eligibility will allow us to further explore the effect tumor location will have on cognitive testing and rsfcMRI. Here, repeated evaluations on and off therapy will provide the necessary data points to establish trajectories of cognitive development and recovery in this population.
Recruiting1 award N/A
Image of trial facility.

ADI-PEG 20 + Ifosfamide + Radiotherapy

for Soft Tissue Sarcoma

In this study, patients with soft tissue sarcoma (STS) will receive ADI-PEG 20 and ifosfamide in combination with radiation as neoadjuvant therapy. In phase I of the study, up to 5 dose levels will be tested to find the recommended phase II dose (RP2D), after which patients enrolling to phase II will be treated at that dose level to assess efficacy.
Recruiting1 award Phase 1 & 2

More about Stephanie Perkins, M.D.

Clinical Trial Related3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Stephanie Perkins, M.D. has experience with
  • Proton Beam Radiation Therapy
  • NIH Toolbox Cognitive Battery
  • Neurocognitive Testing
  • RsfcMRI
  • Photon Radiation Therapy
  • Radiation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephanie Perkins, M.D. specialize in?
Stephanie Perkins, M.D. focuses on Brain Tumor and Cerebral Gliomas. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are undergoing treatment.
Is Stephanie Perkins, M.D. currently recruiting for clinical trials?
Yes, Stephanie Perkins, M.D. is currently recruiting for 4 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Stephanie Perkins, M.D. has studied deeply?
Yes, Stephanie Perkins, M.D. has studied treatments such as Proton Beam Radiation Therapy, NIH Toolbox Cognitive Battery, Neurocognitive testing.
What is the best way to schedule an appointment with Stephanie Perkins, M.D.?
Apply for one of the trials that Stephanie Perkins, M.D. is conducting.
What is the office address of Stephanie Perkins, M.D.?
The office of Stephanie Perkins, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security